INSPIRE: Breast cancer

INSPIRE:breast cancer is the second project in INSPIRE. The project will ensure continuous and regular data collection in the future, and publish the first analyses on medical breast cancer treatment.

Last updated: 11/22/2023

Breast cancer is the second cancer diagnosis in which the INSPIRE project links drug cancer treatment with diagnostic data and other treatment data in the Cancer Registry of Norway. The project works closely with all parties in the project and the analysis council, to provide an overview of the course of treatment for breast cancer. The final report from INSPIRE:breast cancer was published on 7 April 2022. INSPIRE:breast cancer has been completed, and further operation and updating of medical breast cancer treatment is handled by the Quality Registry for Breast Cancer.

Project documents

Contact your project manager for access to the project documents.

Business case
Governance document
Mandate of the Steering Group
Communication guidelines
Mandate of the Analysis Council
Template for agreement with the parties

Organization

Steering group: Representation from all parties and chaired by the Director of the Cancer Registry of Norway
Sub-board: LMI and participating companies
Project group: The Cancer Registry of Norway
Analysis advice: Representation from all parties in the project, FHI, SLV, NPR, hospital procurement and representatives from the quality registry for breast cancer and their professional council

Private - public - voluntary cooperation

INSPIRE:brysktreft was a collaboration between 5 pharmaceutical companies (see list on the right), the Norwegian Cancer Society, Invent2, LMI, the regional health authorities and the Cancer Registry of Norway.

Result

INSPIRE:breast cancer continued the work from INSPIRE:lung cancer which established data collection of drug cancer treatment to the Cancer Registry. The project also resulted in analyses and an overview of medical breast cancer treatment being published for the first time (link to the report to the right). Medical cancer treatment for breast cancer has been prepared for the provision of statistics, and for research and quality assurance.